WeVote
Log In

Bill

Bill

SB 257

AN ACT PERMITTING EMERGENCY MEDICAL TECHNICIANS TO ADMINISTER INTRANASAL GLUCAGON.

2025 Regular Session Introduced by Stephen Harding

Connecticut bill allowing EMTs to administer intranasal glucagon for severe low blood sugar emergencies, enabling faster non-invasive treatment in the field.

REF. TO JOINT COMM. ON Public Health
#emergencymedicaltechnicians
0
WeVote Research Nonpartisan
Bill Summary · SB 257

Legislative bill overview

SB 257 expands the scope of practice for Emergency Medical Technicians (EMTs) in Connecticut to allow them to administer intranasal glucagon to patients experiencing severe hypoglycemia (dangerously low blood sugar). This medication delivery method bypasses the need for intravenous administration, making treatment faster and more accessible in emergency situations.

Why is this important

Severe hypoglycemia can cause seizures, loss of consciousness, and death within minutes. By enabling EMTs to administer intranasal glucagon—a non-invasive form already approved by the FDA—this bill could reduce response time to treatment and improve outcomes for diabetic patients experiencing medical crises. It also aligns Connecticut's protocols with those in many other states that have already authorized this practice.

Potential points of contention

  • Training and certification requirements: Questions remain about what additional training EMTs must receive, who bears those costs, and whether current EMTs need recertification
  • Liability and oversight: Unclear how medication errors or adverse reactions would be handled, and what oversight mechanisms exist to monitor practice patterns
  • Implementation timeline: No specified effective date or transition period for EMT agencies to adopt new protocols and acquire medications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.